Global Diabetes Management Devices Market 2017-2021 - Product Image

Global Diabetes Management Devices Market 2017-2021

  • ID: 4430329
  • Report
  • Region: Global
  • 122 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott
  • B. Braun Melsungen
  • CellNovo
  • Insulet
  • Nova Biomedical
  • Senseonics
  • MORE
About Diabetes Management Devices

Diabetes management devices include insulin delivery systems and blood glucose monitoring devices, which are used to treat diabetes effectively and efficiently with fewer side effects. Diabetes (type 1 and type 2) is a chronic disease condition, which occurs due to glucose impairment. The major factors contributing to the disease include obesity, urbanization, sedentary lifestyle, smoking, an elevated level of cholesterols, and hypertension. Vendors in this market are offering high-end insulin delivery systems (less invasive, sleek, pocket-sized, and portable devices) and continuous glucose monitoring systems, which are highly efficient and have user-friendly features.

The analysts forecast the global diabetes management devices market to grow at a CAGR of 8.08% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global diabetes management devices market for 2017-2021. To calculate the market size, the report considers the sales from insulin delivery systems and continuous blood glucose monitoring systems.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Diabetes Management Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • Dexcom
  • F. Hoffmann-La Roche
  • LifeScan
  • Medtronic
Other prominent vendors
  • AgaMatrix
  • Animas
  • ARKRAY
  • Ascensia Diabetes Care
  • B. Braun Melsungen
  • BD
  • Beta Bionics
  • Bigfoot Biomedical
  • BIONIME USA
  • CellNovo
  • Eli Lilly
  • iHealth Labs
  • Insulet
  • Nemaura Medical
  • Nipro
  • Nova Biomedical
  • Novo Nordisk
  • Panasonic Healthcare
  • Prodigy Diabetes Care
  • Sanofi
  • Senseonics
  • Tandem Diabetes Care
  • Trividia Health
  • TypeZero Technologies
  • Valeritas
  • WellDoc
Market drivers
  • Rising global burden of diabetes
  • For a full, detailed list, view the full report
Market challenges
  • Prohibitive cost of the diabetes care devices
  • For a full, detailed list, view the full report
Market trends
  • Growing focus on artificial pancreas
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • B. Braun Melsungen
  • CellNovo
  • Insulet
  • Nova Biomedical
  • Senseonics
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION
  • Market outline
PART 05: MARKET LANDSCAPE
  • Market overview
  • Five forces analysis
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Comparison by product
  • Insulin delivery systems
  • Blood glucose monitoring devices
  • Market opportunity by product
PART 07: MARKET SEGMENTATION BY END-USERS
  • Hospitals
  • Specialty diabetes clinics
  • Home care settings
  • Others
PART 08: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Diabetes management devices market in Americas
  • Diabetes management devices market in EMEA
  • Diabetes management devices market in APAC
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Growing focus on artificial pancreas
  • Increasing focus on home care settings
  • Technological advancements/improvements
PART 12: VENDOR LANDSCAPE
  • Competitive scenario
  • Key news
  • M&A
PART 13: VENDOR ANALYSIS
  • Vendor overview
  • Abbott
  • Dexcom
  • F. Hoffmann-La Roche
  • LifeScan
  • Medtronic
  • Other prominent vendors
PART 14: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Types of diabetes
Exhibit 02: Risk factors for diabetes
Exhibit 03: Global diabetes management devices market 2016-2021 ($ millions)
Exhibit 04: Five forces
Exhibit 05: Segmentation of global diabetes management devices by product 2016
Exhibit 06: Global diabetes management devices market analysis by product 2016
Exhibit 07: Global diabetes management devices market by product 2016 and 2021 (%)
Exhibit 08: Global diabetes management devices market by product 2016 and 2021 ($ millions)
Exhibit 09: Global diabetes management devices market share by product 2016-2021 (%)
Exhibit 10: Comparison by product
Exhibit 11: Global insulin delivery systems market 2016-2021 ($ millions)
Exhibit 12: Global insulin delivery systems market: Year-over-year (YoY) growth 2017-2021 (%)
Exhibit 13: Global blood glucose monitoring devices market 2016-2021 ($ millions)
Exhibit 14: Global blood glucose monitoring devices market: YoY growth 2017-2021 (%)
Exhibit 15: Global diabetes management devices market: Opportunity by product
Exhibit 16: Global diabetes management devices market by end-users 2016 (%)
Exhibit 17: Global diabetes management devices market analysis by geography 2016
Exhibit 18: Segmentation of global diabetes management devices market by geography 2016 and 2021 ($ millions)
Exhibit 19: Segmentation of global diabetes management devices market by geography 2016 and 2021 (%)
Exhibit 20: Global diabetes management devices market share by geography 2016-2021 (%)
Exhibit 21: Global diabetes management devices market: Regional comparison
Exhibit 22: Diabetes management devices market in Americas 2016-2021 ($ millions)
Exhibit 23: Diabetes management devices market in Americas: YoY growth 2017-2021 (%)
Exhibit 24: Top three countries in Americas
Exhibit 25: Diabetes management devices market in EMEA 2016-2021 ($ millions)
Exhibit 26: Diabetes management devices market in EMEA: YoY growth 2017-2021 (%)
Exhibit 27: Top three countries in EMEA
Exhibit 28: Diabetes management devices market in APAC 2016-2021 ($ millions)
Exhibit 29: Diabetes management devices market in APAC: YoY growth 2017-2021 (%)
Exhibit 30: Top three countries in APAC
Exhibit 31: Prevalence of diabetes 2000 and 2030 (millions)
Exhibit 32: Recent product launches
Exhibit 33: Product recalls
Exhibit 34: Pipeline products
Exhibit 35: Abbott: Key highlights
Exhibit 36: Abbott: Strength assessment
Exhibit 37: Abbott: Strategy assessment
Exhibit 38: Abbott: Opportunity assessment
Exhibit 39: Dexcom: Key highlights
Exhibit 40: Dexcom: Strength assessment
Exhibit 41: Dexcom: Strategy assessment
Exhibit 42: Dexcom: Opportunity assessment
Exhibit 43: F. Hoffmann-La Roche: Key highlights
Exhibit 44: F. Hoffmann-La Roche: Strength assessment
Exhibit 45: F. Hoffmann-La Roche: Strategy assessment
Exhibit 46: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 47: LifeScan: Key highlights
Exhibit 48: LifeScan: Strength assessment
Exhibit 49: LifeScan: Strategy assessment
Exhibit 50: LifeScan: Opportunity assessment
Exhibit 51: Medtronic: Key highlights
Exhibit 52: Medtronic: Strength assessment
Exhibit 53: Medtronic: Strategy assessment
Exhibit 54: Medtronic: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • B. Braun Melsungen
  • CellNovo
  • Insulet
  • Nova Biomedical
  • Senseonics
  • MORE
New Report Released: - Global Diabetes Management Devices Market 2017-2021

The author of the report recognizes the following companies as the key players in the global diabetes management devices market: Abbott, Dexcom, F. Hoffmann-La Roche, LifeScan, and Medtronic

Other Prominent Vendors in the market are: AgaMatrix, Animas, ARKRAY, Ascensia Diabetes Care, B. Braun Melsungen, BD, Beta Bionics, Bigfoot Biomedical, BIONIME USA, CellNovo, Eli Lilly, iHealth Labs, Insulet, Nemaura Medical, Nipro, Nova Biomedical, Novo Nordisk, Panasonic Healthcare, Prodigy Diabetes Care, Sanofi, Senseonics, Tandem Diabetes Care, Trividia Health, TypeZero Technologies, Valeritas, and WellDoc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is Growing focus on artificial pancreas. Diabetes is a serious condition that develops due to the absence of insulin, which is secreted by islets of Langerhans in the pancreas. The artificial pancreas is the newest technology that helps people to manage diabetes automatically by controlling their blood glucose levels by providing the substitute endocrine functionality of healthy pancreas. The launch of the first artificial pancreas by Medtronic has been one of the most revolutionary advances in medical device history. It is a clinically efficient, next-generation insulin pump technology with continuous monitoring of glucose. It has fewer complications and offers greater ability to live without complications.”

According to the report, one of the major drivers for this market is Rising global burden of diabetes. Diabetes is a chronic disease, which occurs when the body cannot use insulin effectively or when the pancreas does not produce enough insulin. Hyperglycemia or increased blood sugar can result in severe damage or complication, which may become life-threatening to the individual if left untreated.

Further, the report states that one of the major factors hindering the growth of this market is Prohibitive cost of the diabetes care devices. Diabetes is a condition, which requires continuous monitoring of the blood glucose levels and insulin treatment. Vendors are offering novel CGM devices and insulin delivery systems, which improve the patient’s quality of life. The devices offer readings with minimal or reduced finger sticks, thereby generating accurate results. However, the novel designs are too expensive for a normal diabetic patient to afford and use, especially in case of developing countries. Traditional insulin therapy involves the use of insulin syringes. However, with the recent technical advances, vendors are offerings insulin jet injectors, insulin pens, insulin patches, and implantable insulin devices, which are highly expensive. For instance, Medtronic’s offering, the MiniMed 670G, has an estimated cost of around $5,000-$8,000 with the annual cost of disposable sensors, which cost another few thousand dollars. Also, the insulin jet injectors, which cost around $300-$700, are costlier when compared with insulin pens.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott
  • Dexcom
  • F. Hoffmann-La Roche
  • LifeScan
  • Medtronic
  • AgaMatrix
  • Animas
  • ARKRAY
  • Ascensia Diabetes Care
  • B. Braun Melsungen
  • BD
  • Beta Bionics
  • Bigfoot Biomedical
  • BIONIME USA
  • CellNovo
  • Eli Lilly
  • iHealth Labs
  • Insulet
  • Nemaura Medical
  • Nipro
  • Nova Biomedical
  • Novo Nordisk
  • Panasonic Healthcare
  • Prodigy Diabetes Care
  • Sanofi
  • Senseonics
  • Tandem Diabetes Care
  • Trividia Health
  • TypeZero Technologies
  • Valeritas
  • WellDoc
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll